Physician-pharmacist collaborative care in dyslipidemia management: The perception of clinicians and patients

Research in Social and Administrative Pharmacy

Volumn 7, Issue 3, 2011, Pages 233-245

  Lalonde, Lyne ^a,b,c   Hudon, Eveline ^a,b   Goudreau, Johanne ^a,b   Bélanger, Danielle ^b   Villeneuve, Julie ^d   Perreault, Sylvie ^a   Blais, Lucie ^a   Lamarre, Diane ^a,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Cité de la Santé Hospital   (Canada)

^c Centre de santé et de services sociaux de Laval   (Canada)

^d SANOFI   (France)

^e Ordre des Sages Femmes du Québec   (Canada)

Author keywords

Community pharmacists; Dyslipidemia; Family physicians; Pharmaceutical care; Physician and pharmacist collaborative care

Indexed keywords

ARTICLE; CANADA; CLINICAL PRACTICE; CLINICAL TRIAL; COOPERATION; DISEASE MANAGEMENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTPATIENT; PHARMACIST; PHARMACY; PHYSICIAN; PRIMARY HEALTH CARE; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; PUBLIC RELATIONS;

COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; DISEASE MANAGEMENT; DYSLIPIDEMIAS; FEMALE; FOCUS GROUPS; FOLLOW-UP STUDIES; HUMANS; INTERPROFESSIONAL RELATIONS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; OUTPATIENTS; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRIMARY HEALTH CARE; PROFESSIONAL ROLE; QUEBEC;

EID: 80052271123     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2010.05.003     Document Type: Article

References (39)

1. Avorn J., Monette J., Lacour A., et al. Persistence of use of lipid-lowering medications. A cross-national study. JAMA 1998, 279:1458-1462.
2. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002, 288:462-467.
3. Bourgault C., Davignon J., Fodor G., et al. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study-Observational (CALIPSO). Can J Cardiol 2005, 21:1187-1193.
4. Farahani P., Levine M. Goal attainment for multiple cardiovascular risk factors in community-based clinical practice (a Canadian experience). J Eval Clin Pract 2009, 15:212-216.
5. Ali F., Laurin M.Y., Lariviere C., Tremblay D., Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol 2003, 10:101-106.
6. Bluml B., McKenney J., Cziraky M. Pharmaceutical care service and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000, 40:157-165.
7. Paulos C.P., Nygren C.E., Celedon C., Carcamo C.A. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother 2005, 39:939-943.
8. Peterson G.M., Fitzmaurice K.D., Naunton M., Vial J.H., Stewart K., Krum H. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 2004, 29:23-30.
9. Tsuyuki R.T., Johnson J.A., Teo K.K., et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002, 162:1149-1155.
10. Community Pharmacy Medicines Management Project Evaluation Team The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007, 24:189-200.
11. Ibrahim O.M., Catania P.N., Mergener M.A., Supernaw R.B. Outcome of cholesterol screening in a community pharmacy. DICP 1990, 24:817-821.
12. Nola K.M., Gourley D.R., Portner T.S., et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc (Wash) 2000, 40:166-173.
13. Shibley M.C., Pugh C.B. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997, 31:713-719.
14. Tsuyuki R.T., Olson K.L., Dubyk A.M., Schindel T.J., Johnson J.A. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med 2004, 116:130-133.
15. Farris K.B., Fernandez-Llimos F., Benrimoj S.I. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother 2005, 39:1539-1541.
16. Wright H. Pharmacist prescribing: ensuring quality (conference presentation). Royal Pharmaceutical Society of Great Britain Available at:, Accessed 21.05.09. http://www.rpsgb.org.uk/pdfs/sciconf070611HW.pdf.
17. Assemblée Nationale du Québec Loi modifiant le Code des professions et d'autres dispositions législatives dans le domaine de la santé Available at:, Accessed 10.10.08. http://www2.publicationsduquebec.gouv.qc.ca/dynamicSearch/telecharge.php%3Ftype%3D5%26file%3D2002C33F.PDF.
18. Alliance for Pharmaceutical Care Collaborative drug therapy management: a coordinated approach to patient care Available at:, Accessed 12.02.09. http://www.pswi.org/professional/patient/drugtherapy.pdf.
19. Villeneuve J., Lamarre D., Vanier M.C., et al. How to help patients manage their dyslipidemia: a primary care physician-pharmacist team intervention. Can Pharm J 2007, 140:300-305.
20. Villeneuve J., Genest J., Blais L., et al. A cluster randomized controlled trial to evaluate an ambulatory primary care management program for patients with dyslipidemia: the TEAM study. CMAJ 2010, 182:447-455.
21. Villeneuve J., Lamarre D., Lussier M.T., et al. Physician-pharmacist collaborative care for dyslipidemia patients: knowledge and skills of community pharmacists. J Contin Educ Health Prof 2009, 29:201-208.
22. Giorgi A. The phenomenological movement and research in the human sciences. Nurs Sci Q 2005, 18:75-82.
23. Lee J.R.E. Prologue: talking organisation. Talk and Social Interaction 1987, Multilingual Matters, Clevedon, PA. G. Button, J.R.E. Lee (Eds.).
24. Mucchielli A. Phénoménologique. Dictionnaire des méthodes qualitatives en sciences humaines et sociales 1996, [analyse], Armand Colin, Paris.
25. McPherson R., Frohlich J., Fodor G., Genest J., Canadian Cardiovascular Society Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006, 22:913-927.
26. D'Amour D., Sicotte C., Lévy R. L'action collective au sein d'équipes professionnelles dans les services de santé. Sciences Sociales et Santé 1999, 17:67-92.
27. Moreau A., Dedianne M.C., Letrilliart L., LeGoaziou M.F., Labarère J., Terra J.L. Recherche en médecine générale. Méthode de recherche. S'approprier la méthode du focus group. Rev Prat-Médecine Générale 2004, 18:382-384.
28. Patton M.Q. Qualitative Evaluation and Research Methods 1990, Sage Publications, Newbury Park. 2nd ed.
29. Giorgi A. An application of phenomenological method. Duquesne Studies in Phenomenological Psychology 1975, Vol. II. Duquesne University Press, Pittsburgh. A. Giorgi, C. Fischer, E. Murray (Eds.).
30. Whittemore R., Chase S.K., Mandle C.L. Validity in qualitative research. Qual Health Res 2001, 11:522-537.
31. Savoie-Zajc L. Acceptation interne (critère d'). Dictionnaire des méthodes qualitatives en sciences humaines et sociales 1996, Armand Collin, Paris. A. Mucchielli (Ed.).
32. Gladu F.P. Perceived shortage of family doctors in Quebec: can we do something about it?. Can Fam Physician 2007, 53:1858-1860. 1871-1853.
33. Association médicale canadienne Oui aux soins partagés, mais pas à n'importe quel prix. L'actualité médicale 2007, 12:4-5.
34. Tinelli M., Bond C., Blenkinsopp A., Jaffray M., Watson M., Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother 2007, 41:1962-1970.
35. Pottie K., Farrell B., Haydt S., et al. Integrating pharmacists into family practice teams: physicians' perspectives on collaborative care. Can Fam Physician 2008, 54:1714-1717. e1715.
36. Alkhateeb F.M., Unni E., Latif D., Shawaqfeh M.S., Al-Rousan R.M. Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists' responsibilities in West Virginia. J Am Pharm Assoc (2003) 2009, 49:797-800.
37. Howard M., Trim K., Woodward C., et al. Collaboration between community pharmacists and family physicians: lessons learned from the Seniors Medication Assessment Research Trial. J Am Pharm Assoc (Wash DC) 2003, 43:566-572.
38. McDonough R., Doucette W. Dynamics of pharmaceutical care: developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc (Wash) 2001, 41:682-692.
39. D'Amour D., Ferrada-Videla M., San Martin Rodriguez L., Beaulieu M.D. The conceptual basis for interprofessional collaboration: core concepts and theoretical frameworks. J Interprof Care 2005, (19 suppl 1):116-131.